United States · FDA National Drug Code directory
MARGENZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 74527-022_97ee3be5-cd7f-45d4-85c7-b48ad596e837
- Product NDC
- 74527-022
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- margetuximab-cmkb
- Labeler
- MacroGenics, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210115
- Source listing expiry
- 20261231
Source-listed ingredients
- MARGETUXIMAB — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01) · 74527-022-02
- 4 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-03) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01) · 74527-022-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →